I have indeed been following the discussion hence my response. Lambasting the FDA over the issuance of the CRL is childish nonsense. I'm sure SI and his team will do their best to convince the FDA that their pathway is more prudent. Not sure what mates you refer to???
MSB to dispute FDA finding in Type A meeting, page-564
-
- There are more pages in this discussion • 454 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.040(3.36%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $3.615M | 3.052M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 58497 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 150498 | 10 |
View Market Depth
| Last trade - 12.42pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |